Positive results for monthly HIV drug
Johnson & Johnson/ViiV’s once-monthly, injectable drug combination for HIV shows comparable efficacy to daily oral treatment in two trials.
Read More
Tag: Conference on Retroviruses and Opportunistic Infections
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
